William C. Sessa PhD
Alfred Gilman Professor of Pharmacology and Professor of Medicine (Cardiology); Vice Chairman, Pharmacology; Director, Vascular Biology & Therapeutics Program
- International Scientific Board
London, United Kingdom(2012 - 2017)
Dr. Sessa is a member of the Scientific Advisory Board to the William Harvey Research Institute [WHRI] and the NIHR Biomedical Research Unit [BRU] in London.
- Cardiovascular Research
Yale-Cambridge Program in Cardiovascular Research that focuses on arteriosclerosis, angiogenisis, vascular injury, and transplantation.
- YALE-UCL Collaborative
London, United Kingdom(2011)
Dr. Sessa is on the Joint Strategy Committee for the Yale-UCL Collaborative, an alliance which will provide opportunities for high-level scientific research, clinical and educational collaboration across the institutions involved: Yale University, Yale School of Medicine, Yale-New Haven Hospital and UCL (University College London) and UCL Partners.
Education & Training
- New York Medical College (1989)
- Post-doctoral fellow/Senior Scientist
- The William Harvey Research Institute
- Post-doctoral fellow
- Pharmacology, The University of Virginia Health Sciences Center